# SIROLIMUS
> **ANDA211406** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-10-22
## Drug
- **FDA Application Number:** ANDA211406
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SIROLIMUS
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp
- **First approval:** 2019-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211406)
---
*AI Analytics · CC0 1.0*